Monoclonal Antibodies
Nonhormonal Contraceptive Ring for Birth Control
Recruiting0 awards3 criteria
Galveston, Texas
This trial will test a new vaginal ring that acts as a nonhormonal contraceptive by using anti-sperm antibodies. It is important to assess the safety and acceptability of this device early on in
Behavioral Intervention
Goal Attainment Scaling for Peripheral Neuropathy
Recruiting1 award4 criteria
Houston, Texas
This trial focuses on helping patients figure out what is most important to them. It is part of a bigger plan to shift healthcare from just treating diseases to taking care of the entire person. "This trial
Participants With Signs and Symptoms of Acute Coronary Syndromes for Heart Attack
Recruiting1 award10 criteria
Houston, Texas
This prospective, non-interventional, single arm, longitudinal cohort multicenter study will recruit approximately 5600 consecutive all-comers, consisting of patients with signs and symptoms of acute coronary syndromes (ACS) who present in the emergency department (ED). The main objective of the study is to determine the clinical performance of Elecsys Troponin T hs Gen 6 versus the centrally adjudicated clinical diagnosis at various time points after ED presentation using the previously determined clinical cut-off of a universal 99th percentile upper reference limit.
Popular Filters
Phase 3 Trials
Corticosteroid
Baxdrostat + Dapagliflozin for Chronic Kidney Disease and High Blood Pressure
Recruiting1 awardPhase 3
Houston, Texas
This trial will test a new medication called Baxdrostat with Dapagliflozin to see if it can improve kidney health and reduce the risk of heart problems in people with chronic kidney
Aviptidil + SOC for Coronavirus
Recruiting1 awardPhase 3
Houston, Texas
This study looks at the safety and effectiveness of Aviptidil in treating COVID-19 in people who have been hospitalized with the infection and who have acute respiratory failure. Participants in the study will be treated with Aviptidil plus current standard of care (SOC), or with placebo plus current SOC.
Remdesivir + SOC for Coronavirus
Recruiting1 awardPhase 3
Houston, Texas
This study looks at the safety and effectiveness of Remdesivir in treating COVID-19 in people who have been hospitalized with the infection and who have acute respiratory failure. Participants in the study will be treated with Remdesivir plus current standard of care (SOC), or with placebo plus current SOC.
Trials With No Placebo
Ultrasound Algorithms for Pregnancy
Recruiting1 award1 criteria
Houston, Texas
This trial aims to collect ultrasound data from both pregnant and non-pregnant individuals at different study locations. The data will be used to train and test artificial intelligence algorithms created by the Sponsor. Participants who
View More Related Trials
Frequently Asked Questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.